Literature DB >> 19075838

Plasmid DNA manufacturing technology.

Aaron E Carnes1, James A Williams.   

Abstract

Today, plasmid DNA is becoming increasingly important as the next generation of biotechnology products (gene medicines and DNA vaccines) make their way into clinical trials, and eventually into the pharmaceutical marketplace. This review summarizes recent patents and patent applications relating to plasmid manufacturing, in the context of a comprehensive description of the plasmid manufacturing intellectual property landscape. Strategies for plasmid manufacturers to develop or in-license key plasmid manufacturing technologies are described with the endpoint of efficiently producing kg quantities of plasmid DNA of a quality that meets anticipated European and FDA quality specifications for commercial plasmid products.

Mesh:

Substances:

Year:  2007        PMID: 19075838     DOI: 10.2174/187220807780809436

Source DB:  PubMed          Journal:  Recent Pat Biotechnol        ISSN: 1872-2083


  12 in total

Review 1.  Plasmid DNA vaccine vector design: impact on efficacy, safety and upstream production.

Authors:  James A Williams; Aaron E Carnes; Clague P Hodgson
Journal:  Biotechnol Adv       Date:  2009-02-20       Impact factor: 14.227

2.  Evaluation of a Novel Plasmid for Simultaneous Gene Electrotransfer-Mediated Silencing of CD105 and CD146 in Combination with Irradiation.

Authors:  Monika Savarin; Urska Kamensek; Katarina Znidar; Vesna Todorovic; Gregor Sersa; Maja Cemazar
Journal:  Int J Mol Sci       Date:  2021-03-17       Impact factor: 5.923

3.  Tumor-specific expression and detection of a CEST reporter gene.

Authors:  Il Minn; Amnon Bar-Shir; Keerthi Yarlagadda; Jeff W M Bulte; Paul B Fisher; Hao Wang; Assaf A Gilad; Martin G Pomper
Journal:  Magn Reson Med       Date:  2015-04-27       Impact factor: 4.668

4.  Generic plasmid DNA production platform incorporating low metabolic burden seed-stock and fed-batch fermentation processes.

Authors:  James A Williams; Jeremy Luke; Sarah Langtry; Sheryl Anderson; Clague P Hodgson; Aaron E Carnes
Journal:  Biotechnol Bioeng       Date:  2009-08-15       Impact factor: 4.530

5.  Antibiotic-free production of a herpes simplex virus 2 DNA vaccine in a high yield cGMP process.

Authors:  Jared Nelson; Stephen Rodriguez; Neil Finlayson; Jim Williams; Aaron Carnes
Journal:  Hum Vaccin Immunother       Date:  2013-07-30       Impact factor: 3.452

Review 6.  Molecular-genetic imaging of cancer.

Authors:  Il Minn; Mitchell E Menezes; Siddik Sarkar; Keerthi Yarlagadda; Swadesh K Das; Luni Emdad; Devanand Sarkar; Paul B Fisher; Martin G Pomper
Journal:  Adv Cancer Res       Date:  2014       Impact factor: 6.242

7.  Improved antibiotic-free DNA vaccine vectors utilizing a novel RNA based plasmid selection system.

Authors:  Jeremy Luke; Aaron E Carnes; Clague P Hodgson; James A Williams
Journal:  Vaccine       Date:  2009-06-24       Impact factor: 3.641

8.  Polyclonal antibody cocktails generated using DNA vaccine technology protect in murine models of orthopoxvirus disease.

Authors:  Joseph W Golden; Marina Zaitseva; Senta Kapnick; Robert W Fisher; Malgorzata G Mikolajczyk; John Ballantyne; Hana Golding; Jay W Hooper
Journal:  Virol J       Date:  2011-09-20       Impact factor: 4.099

Review 9.  Vector Design for Improved DNA Vaccine Efficacy, Safety and Production.

Authors:  James A Williams
Journal:  Vaccines (Basel)       Date:  2013-06-25

10.  Optimization of fermentation conditions for an Escherichia coli strain engineered using the response surface method to produce a novel therapeutic DNA vaccine for rheumatoid arthritis.

Authors:  Juan Long; Xiao Zhao; Fei Liang; Nan Liu; Yuying Sun; Yongzhi Xi
Journal:  J Biol Eng       Date:  2018-10-10       Impact factor: 4.355

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.